20Slash20 Showcases Eye Drink at Moody Capital’s Disruptive Growth & Life Sciences Conference
Found this article helpful?
Share it with your network and spread the knowledge!
Austin, Texas-based 20Slash20 Inc. is making waves in the preventive eyecare industry with its flagship product, The Eye Drink, which was featured at the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference. The company, which describes itself as a pioneer in ready-to-drink functional beverages, aims to address the ocular challenges posed by today’s screen-heavy lifestyles.
The Eye Drink is positioned as the world’s first clinically inspired beverage specifically formulated to minimize ocular issues arising from prolonged screen use. It targets individuals who spend long hours staring at computers or cellphones, helping to reduce screen-induced dry eyes and macular damage. The formulation relies on science-backed nutrients based on the AREDS 2 Studies, along with vegan-friendly triglyceride-formed Omega-3, to support visual performance and enhance ocular comfort.
By converting clinical science into a simple, delicious daily habit, 20Slash20 is modernizing preventive eyecare. The company distributes through direct-to-consumer channels, professional medical affiliates, and natural product retail stores, making its product accessible to a broad audience. This approach reflects a growing trend in the health and wellness industry, where consumers are increasingly seeking proactive solutions to mitigate the effects of modern living.
The conference, organized by Moody Capital Solutions, brought together disruptive growth companies and life sciences leaders, providing a platform for innovation and investment opportunities. Moody Capital Solutions, an independent full-service investment bank with over 40 years of experience in capital raising, M&A, and advisory services, hosted the event. The firm is recognized as a market leader in rights offerings and is a member of FINRA/SIPC.
IBN, a multifaceted financial news and publishing company, provided extensive coverage of the conference. Through its custom-built portal, IBN offered summaries of each participating company, including 20Slash20, and facilitated access to market research tools and relevant websites. IBN leveraged social media and syndicated articles to maximize event visibility, ensuring that innovative companies like 20Slash20 gain exposure to a wide audience of investors and industry stakeholders.
The significance of 20Slash20’s participation lies in its potential to impact the functional beverage market and the broader eyecare industry. With millions of people worldwide experiencing digital eye strain, the demand for effective, convenient solutions is rising. The Eye Drink’s clinically inspired formula could set a new standard for preventive eyecare, appealing not only to consumers but also to healthcare professionals seeking evidence-based recommendations for their patients.
For more information about The Eye Drink, visit theeyedrink.com. Details about the conference and Moody Capital Solutions can be found at moodycapital.com/conference, and IBN’s full coverage is available at ibn.fm/MoodyCapital2026Conference.